Tim Van-Assche - JoVE Visualize

Showing results (21-30 of 24) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 24 results.

European Stroke Journal|November 29, 2024

Gadolinium leakage into ocular structures as a marker in stroke: A retrospective analysis of the WAKE-UP trialAnke Wouters, Tim Van Assche, Lauranne Scheldeman, et al.

Journal of the American College of Cardiology|July 5, 2008

GCH1 haplotype determines vascular and plasma biopterin availability in coronary artery disease effects on vascular superoxide production and endothelial functionCharalambos Antoniades, Cheerag Shirodaria, Tim Van Assche, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 17, 2016

First-in-Human Study in Healthy Subjects with FR104, a Pegylated Monoclonal Antibody Fragment Antagonist of CD28Nicolas Poirier, Gilles Blancho, Maryvonne Hiance, et al.

Circulation|February 9, 2012

Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery diseaseColin Cunnington, Tim Van Assche, Cheerag Shirodaria, et al.

Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 24 results.

European Stroke Journal|November 29, 2024

Gadolinium leakage into ocular structures as a marker in stroke: A retrospective analysis of the WAKE-UP trialAnke Wouters, Tim Van Assche, Lauranne Scheldeman, et al.

Journal of the American College of Cardiology|July 5, 2008

GCH1 haplotype determines vascular and plasma biopterin availability in coronary artery disease effects on vascular superoxide production and endothelial functionCharalambos Antoniades, Cheerag Shirodaria, Tim Van Assche, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 17, 2016

First-in-Human Study in Healthy Subjects with FR104, a Pegylated Monoclonal Antibody Fragment Antagonist of CD28Nicolas Poirier, Gilles Blancho, Maryvonne Hiance, et al.

Circulation|February 9, 2012

Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery diseaseColin Cunnington, Tim Van Assche, Cheerag Shirodaria, et al.

Pageof 3